• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[因宗教原因不接受异体输血患者的严重、危及生命的肾性贫血治疗——病例报告]

[Severe, life-threatening renal anemia treatment in patients who do not accept heterologous blood transfusion for religious reasons--case report].

作者信息

Jaroszyński Andrzej J, Bober-Palak Ewa, Jóźwiak Lucyna, Ksiazek Andrzej

机构信息

Katedra i Klinika Nefrologii Akademii Medycznej w Lublinie.

出版信息

Przegl Lek. 2007;64(7-8):528-30.

PMID:18409359
Abstract

The management of severe anemia in patients who do not accept heterologous blood transfusion for religious reasons presents many different challenges both at the level of treatment strategy and ethics. Recently, new interventional treatment strategies have become available, including human and bovine hemoglobin substitutes and high-dose recombinant human erythropoietin. We present the successful management of two Jehovah's Witnesses patients with severe, life-threatening anemia caused by chronic renal failure and exacerbated by sepsis.

摘要

对于因宗教原因不接受异体输血的患者,重度贫血的管理在治疗策略和伦理层面都面临诸多不同挑战。近来,出现了新的介入治疗策略,包括人源和牛源血红蛋白替代品以及高剂量重组人促红细胞生成素。我们介绍了两名耶和华见证会患者重度、危及生命的贫血的成功管理案例,其贫血由慢性肾衰竭引起,并因败血症而加重。

相似文献

1
[Severe, life-threatening renal anemia treatment in patients who do not accept heterologous blood transfusion for religious reasons--case report].[因宗教原因不接受异体输血患者的严重、危及生命的肾性贫血治疗——病例报告]
Przegl Lek. 2007;64(7-8):528-30.
2
Recombinant human erythropoietin therapy in critically ill Jehovah's Witnesses.重组人促红细胞生成素治疗危重症耶和华见证会信徒
Pharmacotherapy. 2008 Nov;28(11):1383-90. doi: 10.1592/phco.28.11.1383.
3
Use of erythropoietin in Jehovah's Witness patients.
Hawaii Med J. 1990 Jun;49(6):209.
4
Severe anemia in the Jehovah's Witness: case report and discussion.耶和华见证人中的严重贫血:病例报告与讨论
Am J Crit Care. 1993 May;2(3):256-9.
5
[Requirement for blood in hemodialyzed patients with chronic renal failure in the period before and after introduction to erythropoietin (r-HuEPO) treatment].[慢性肾衰竭血液透析患者在引入促红细胞生成素(r-HuEPO)治疗前后时期的血液需求]
Przegl Lek. 1996;53(12):866-9.
6
An unusual etiology of erythropoietin resistance: hyperthyroidism.促红细胞生成素抵抗的一种罕见病因:甲状腺功能亢进症。
Ren Fail. 2007;29(6):759-61. doi: 10.1080/08860220701460442.
7
[Case of early pronounced anemia and its effective treatment with human recombinant erythropoietin in a female patient with polycystic kidney in a conservative stage of chronic renal failure].[一例慢性肾衰竭保守期多囊肾女性患者早期明显贫血及其用人重组促红细胞生成素的有效治疗病例]
Ter Arkh. 1999;71(6):70-1.
8
Successful treatment of anemia in idiopathic myelofibrosis with recombinant human erythropoietin.重组人促红细胞生成素成功治疗特发性骨髓纤维化贫血
Am J Hematol. 2002 Jun;70(2):92-9. doi: 10.1002/ajh.10076.
9
[Use of human recombinant erythropoietin in children with cancer].[重组人促红细胞生成素在患癌儿童中的应用]
Arch Pediatr. 2005 Sep;12(9):1376-82. doi: 10.1016/j.arcped.2005.05.006.
10
Orally administrated Juzen-taiho-to/TJ-48 ameliorates erythropoietin (rHuEPO)-resistant anemia in patients on hemodialysis.口服十全大补汤/TJ - 48可改善血液透析患者对促红细胞生成素(rHuEPO)抵抗性贫血的症状。
Hemodial Int. 2008 Oct;12 Suppl 2:S9-S14. doi: 10.1111/j.1542-4758.2008.00317.x.